Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.745 USD | -2.66% | -3.68% | -32.89% |
05-13 | Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating | MT |
05-10 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.89% | 374M | |
+64.10% | 62.59B | |
-1.18% | 41.18B | |
+44.76% | 40.29B | |
-8.29% | 27.9B | |
+13.27% | 26.21B | |
-21.52% | 19.09B | |
+5.51% | 13.08B | |
+25.07% | 12.26B | |
+28.39% | 12.05B |
- Stock Market
- Equities
- ORGO Stock
- News Organogenesis Holdings Inc.
- Transcript : Organogenesis Holdings Inc., Q2 2023 Earnings Call, Aug 09, 2023